CClinicalTrials.gg
Status unknownNCT02994862Updated Dec 16, 2016

E. Max Laminate Veneers With and Without Using Galla Chinnesis as Natural Cross Linking and Remineralizing Agent

An interventional study of Galla Chinnesis and Conventional Bonding in Amelogenesis Imperfecta, sponsored by Cairo University. Status unknown. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2016-12-16.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2016), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

In teeth requiring laminate veneers with amelogenesis imperfecta Will application of galla chinensis before Bonding of laminate veneers with adhesive resin cement provide better survival rate than conventional Bonding method

Read the detailed description

one year Clinical evaluation of laminate veneers with amelogenesis imperfecta Will application of galla chinensis before Bonding of laminate veneers with adhesive resin cement provide better survival rate than conventional Bonding method

02

Conditions studied

  • Amelogenesis Imperfecta
03

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

All subjects are required to be:

  • From 18-60 years old, and able to read and sign the informed consent document.
  • Physically and psychologically able to tolerate conventional restorative procedures
  • Have no active periodontal or pulpal diseases, have teeth with good restorations
  • Patients with teeth problems indicated for laminate veneer (e.g. discoloration, fracture not involve more than 50% enamel loss, mild malposition, ....)
  • Willing to return for follow-up examinations and evaluation

Exclusion criteria

Exclusion Criteria:

  • Patients in the growth stage with partially erupted teeth
  • Patient with fractured teeth of more than 50% enamel loss
  • Patients with poor oral hygiene and motivation
  • Pregnant women
  • Psychiatric problems or unrealistic expectations
  • Lack of opposite occluding dentition in the area intended for restoration
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
16 participants (estimated)

Study arms

  • Experimental
    Galla Chinnesis

    new Remineralizing Agent before Bonding to teeth with amelogenesis imperfecta

    Other: Galla Chinnesis

  • Active comparator
    Conventional Bonding

    Normal Bonding Method

    Other: Conventional Bonding

Interventions

  • OtherGalla Chinnesis

    new Remineralizing Agent before Bonding to teeth with amelogenesis imperfecta

  • OtherConventional Bonding

    Normal Bonding Protocol

05

What researchers measure

Primary outcomes

  1. marginal adaptation assessed by clinical evaluation using dental mirror and probe

    clinical evaluation of marginal adaptation

    Time frame: 1 year

Secondary outcomes

  1. Patient satisfaction assessed using a Questionnaire

    Questionnaire for patient satisfaction

    Time frame: 1 Year

06

Study locations

No study locations are listed for this record.

07

References and documents

Publications

  • Cheng L, ten Cate JM. Effect of Galla chinensis on the in vitro remineralization of advanced enamel lesions. Int J Oral Sci. 2010 Mar;2(1):15-20. doi: 10.4248/IJOS10019. PubMed 20690414 ↗

Individual participant data

Plan to share: Undecided

08

Registry details

Key details

Study ID
NCT02994862
Lead sponsor
Cairo University
Responsible party
Mohammed Gamal Fahmy Mohammed (B.D.S, Cairo University) — Principal investigator
First posted
Dec 16, 2016
Start date
Dec 2016
Primary completion
Dec 2017 (estimated)
Completion
Dec 2017 (estimated)
Last update
Dec 16, 2016

Study contacts

Mohammed mohammed, B.D.S
Contact
mgamal400@gmail.com
01226500339
Jylan Elguindy, Phd
Contact

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion